122 related articles for article (PubMed ID: 38097141)
1. Design, synthesis, and biological evaluation of novel 8-substituted quercetin derivatives targeting the β‑catenin/B-cell lymphoma 9 interaction.
Peng X; Shen LA; Bao Y; Liu C; Chen Q; Zhang H; Li J; Zhang Q
Bioorg Med Chem Lett; 2024 Jan; 98():129591. PubMed ID: 38097141
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Novel 3-Phenylpiperidine Derivatives Targeting the β-Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD-1 Antibody for the Treatment of Colorectal Cancer.
Zhang H; Liu C; Chen Q; Shen LA; Xiao W; Li J; Wang Y; Zhu D; Zhang Q; Li J
J Med Chem; 2023 Jan; 66(2):1349-1379. PubMed ID: 36630177
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of quercetin derivatives as novel β-catenin/B-cell lymphoma 9 protein-protein interaction inhibitors.
Shen LA; Peng X; Bao Y; Liu C; Zhang H; Li J; Zhu D; Zhang Q
Eur J Med Chem; 2023 Feb; 247():115075. PubMed ID: 36599228
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 2-(3-(3-Carbamoylpiperidin-1-yl)phenoxy)acetic Acid Derivatives as Novel Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
Wang Z; Zhang M; Luo W; Zhang Y; Ji H
J Med Chem; 2021 May; 64(9):5886-5904. PubMed ID: 33902288
[TBL] [Abstract][Full Text] [Related]
5. A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer.
Tanton H; Sewastianik T; Seo HS; Remillard D; Pierre RS; Bala P; Aitymbayev D; Dennis P; Adler K; Geffken E; Yeoh Z; Vangos N; Garbicz F; Scott D; Sethi N; Bradner J; Dhe-Paganon S; Carrasco RD
Sci Adv; 2022 Apr; 8(17):eabm3108. PubMed ID: 35486727
[TBL] [Abstract][Full Text] [Related]
6. Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling.
Takada K; Zhu D; Bird GH; Sukhdeo K; Zhao JJ; Mani M; Lemieux M; Carrasco DE; Ryan J; Horst D; Fulciniti M; Munshi NC; Xu W; Kung AL; Shivdasani RA; Walensky LD; Carrasco DR
Sci Transl Med; 2012 Aug; 4(148):148ra117. PubMed ID: 22914623
[TBL] [Abstract][Full Text] [Related]
7. LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction.
Li J; Chen X; Ding X; Cheng Y; Zhao B; Lai ZC; Al Hezaimi K; Hakem R; Guan KL; Wang CY
Cell Rep; 2013 Dec; 5(6):1650-63. PubMed ID: 24360964
[TBL] [Abstract][Full Text] [Related]
8. Structure-Based Optimization of Small-Molecule Inhibitors for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
Zhang M; Wang Z; Zhang Y; Guo W; Ji H
J Med Chem; 2018 Apr; 61(7):2989-3007. PubMed ID: 29566337
[TBL] [Abstract][Full Text] [Related]
9. SOX7 Suppresses Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction.
Fan R; He H; Yao W; Zhu Y; Zhou X; Gui M; Lu J; Xi H; Deng Z; Fan M
DNA Cell Biol; 2018 Feb; 37(2):126-132. PubMed ID: 29271667
[TBL] [Abstract][Full Text] [Related]
10. The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway.
Monin MB; Krause P; Stelling R; Bocuk D; Niebert S; Klemm F; Pukrop T; Koenig S
J Surg Res; 2016 Jun; 203(1):193-205. PubMed ID: 27338550
[TBL] [Abstract][Full Text] [Related]
11. The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells.
de la Roche M; Worm J; Bienz M
BMC Cancer; 2008 Jul; 8():199. PubMed ID: 18627596
[TBL] [Abstract][Full Text] [Related]
12. LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling.
Guan B; Ma J; Yang Z; Yu F; Yao J
Environ Toxicol; 2021 Aug; 36(8):1640-1653. PubMed ID: 33974352
[TBL] [Abstract][Full Text] [Related]
13. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells.
Srivastava NS; Srivastava RAK
Phytomedicine; 2019 Jan; 52():117-128. PubMed ID: 30599890
[TBL] [Abstract][Full Text] [Related]
14. New ZW4864 Derivatives as Small-Molecule Inhibitors for the β-Catenin/BCL9 Protein-Protein Interaction.
Wang Z; Zhang M; Thompson HM; Ji H
ACS Med Chem Lett; 2022 May; 13(5):865-870. PubMed ID: 35586435
[TBL] [Abstract][Full Text] [Related]
15. Dehydroxyhispolon Methyl Ether, A Hispolon Derivative, Inhibits WNT/β-Catenin Signaling to Elicit Human Colorectal Carcinoma Cell Apoptosis.
Fan HC; Hsieh YC; Li LH; Chang CC; Janoušková K; Ramani MV; Subbaraju GV; Cheng KT; Chang CC
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266494
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cells.
Kim H; Seo EM; Sharma AR; Ganbold B; Park J; Sharma G; Kang YH; Song DK; Lee SS; Nam JS
Int J Oncol; 2013 Oct; 43(4):1319-25. PubMed ID: 23900432
[TBL] [Abstract][Full Text] [Related]
17. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells.
Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC
Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of aquaporin-5 sensitizes colorectal cancer cells to 5-fluorouracil via inhibition of the Wnt-β-catenin signaling pathway.
Li Q; Yang T; Li D; Ding F; Bai G; Wang W; Sun H
Biochem Cell Biol; 2018 Oct; 96(5):572-579. PubMed ID: 29390193
[TBL] [Abstract][Full Text] [Related]
19. Isoquercitrin suppresses colon cancer cell growth in vitro by targeting the Wnt/β-catenin signaling pathway.
Amado NG; Predes D; Fonseca BF; Cerqueira DM; Reis AH; Dudenhoeffer AC; Borges HL; Mendes FA; Abreu JG
J Biol Chem; 2014 Dec; 289(51):35456-67. PubMed ID: 25359775
[TBL] [Abstract][Full Text] [Related]
20. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.
Wang Y; Bao X; Zhao A; Zhang J; Zhang M; Zhang Q; Ma B
Life Sci; 2018 Aug; 207():532-549. PubMed ID: 29972765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]